Skip to main content

NIH Chemical Genomics Center to Use Teranode Technology

NEW YORK, Jan. 10 (GenomeWeb News) - Teranode said today that the National Institutes of Health's Chemical Genomics Center will use its Teranode Design Suite to provide a platform between the center and external organizations.

 

Teranode's technology will be used to publish and exchange assay designs, screening protocols, and screening results. Specific terms of the agreement were not disclosed.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.